Suchergebnisse - "Gulbrandsen, Nina"

PubPharm (46)

21

Quality of life, physical function and MRI T2* in elderly low-risk MDS patients treated to a haemoglobin level of ≥120 g/L with darbepoetin alfa ± filgrastim or erythrocyte transfusions

enthalten in: European journal of haematology | 2011

von Nilsson-Ehle, H. | Birgegård, G. | Samuelsson, J. | +11

22

Quality of life, physical function and MRI T2* in elderly low‐risk MDS patients treated to a haemoglobin level of ≥120 g/L with darbepoetin alfa ± filgrastim or erythrocyte transfusions

enthalten in: European journal of haematology | 2011

von Nilsson‐Ehle, H. | Birgegård, G. | Samuelsson, J. | +11

23

Melphalan and prednisone plus thalidomide or placebo in elderly patients with multiple myeloma

enthalten in: Blood | 2010

von Waage, A. | Gimsing, P. | Fayers, P. | +23

CommentIn: Blood. 2010 Sep 2;116(9):1390-1. - PMID 20813903

24

Melphalan and prednisone plus thalidomide or placebo in elderly patients with multiple myeloma

enthalten in: Blood | 2010

von Waage, A. | Gimsing, P. | Fayers, P. | +22

25

Reduced nutritional status among multiple myeloma patients during treatment with high-dose chemotherapy and autologous stem cell support

enthalten in: Clinical nutrition (Edinburgh, Scotland) | 2010

von Iversen, P. | Wisløff, F. | Gulbrandsen, N.

26

Reduced nutritional status among multiple myeloma patients during treatment with high-dose chemotherapy and autologous stem cell support

enthalten in: Clinical nutrition | 2010

von Iversen, P. | Wisløff, F. | Gulbrandsen, N.

27

UK Myeloma Forum (UKMF) and Nordic Myeloma Study Group (NMSG) : guidelines for the investigation of newly detected M-proteins and the management of monoclonal gammopathy of undetermined significance (MGUS)

enthalten in: British journal of haematology | 2009

von Bird, J. | Behrens, J. | Westin, J. | +10

ErratumIn: Br J Haematol. 2010 Feb;148(3):491

28

Health-related quality of life assessment in randomised controlled trials in multiple myeloma : a critical review of methodology and impact on treatment recommendations

enthalten in: European journal of haematology | 2009

von Kvam, A. | Fayers, P. | Hjermstad, M. | +2

29

Health-related quality of life assessment in randomised controlled trials in multiple myeloma: a critical review of methodology and impact on treatment recommendations

enthalten in: European journal of haematology | 2009

von Kvam, A. | Fayers, P. | Hjermstad, M. | +2

30

UK Myeloma Forum (UKMF) and Nordic Myeloma Study Group (NMSG): guidelines for the investigation of newly detected M-proteins and the management of monoclonal gammopathy of undetermined significance (MGUS)

enthalten in: British journal of haematology | 2009

von Bird, J. | Behrens, J. | Westin, J. | +9